EHC at a glance
Encompass Health Corp (EHC, SEC CIK 785161) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 3, 2026, an 8-K current report on November 6, 2026 and Form 4 insider filings as recently as October 19, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Encompass Health Corp (EHC) reported revenue of $5.9 billion (up 10.5% from FY2024) and net income of $566.2 million. Diluted EPS was $5.54.
- As of September 30, 2026, 40 institutional investment managers tracked by SignalX reported holding Encompass Health Corp (EHC) shares worth $5.7 billion in 13F-HR filings.
- In the last 90 days, EHC insiders reported 0 open-market purchases ($0) and 2 open-market sales ($1.2M) on Form 4, a net sale of $1.2M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $5.9B
- +10.5% vs prior year
- Insiders · 90 days
- 0 buys · 2 sells
- Net −$1.2M
- 13F holders
- 40 funds
- $5.7B · +1 vs prior quarter
- Latest 8-K
- Nov 6, 2026
- Item 7.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Risk Factors
- No material changes from 2025 Form 10-K risk factors
- Updated risk information incorporated from MD&A’s “Executive Overview, Key Challenges” section
Management Discussion & Analysis
- Revenue $1,609.5M, up 8.9% YoY, driven by 5.7% discharge growth and 4.0% higher revenue per discharge
- Net income attributable to Encompass Health $149.9M, up 18.5% YoY; operating expenses 82.1% vs 83.5% of revenue
- Inpatient revenue $1,569.1M, up 9.9% YoY; other revenue $40.4M, down 19.5%
- Cash $76.2M; operating cash flow $957.7M through nine months vs $829.6M; capital expenditures approximately $617M
- Outlook: 2027 IRF rule expected to increase Medicare payment rates approximately 2.3%; RCD expansion affects 108 IRFs and approximately 63% of Medicare claims
AI summary of the EHC 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item EX-99.1: Item EX-99.1
- Sea Pines, a 90-bed joint-venture hospital, closed indefinitely after flooding caused substantial damage
- Reopening requires refurbishment or replacement, creating uncertain timing and potential capital needs
Item 7.01: Regulation FD Disclosure
- Press release announces storm-related damage at one Florida hospital, creating potential disruption, repair costs, and temporary operating pressure
- Investor impact depends on facility downtime, insurance recovery, and whether damage affects systemwide Adjusted EBITDA or debt covenants
Item EX-99.1: Item EX-99.1
- Q3 revenue $1,609.5M, up 8.9%, with discharges up 5.7% and revenue per discharge up 4.0%
- Adjusted EBITDA $346.6M, up 15.5%, outpacing revenue growth and supporting operating leverage
Item EX-99.2: Item EX-99.2
- Q3 revenue $1,609.5M, up 8.9%, with discharges up 5.7% and revenue per discharge up 4.0%
- Adjusted EBITDA $346.6M, up 15.5%, expanding operating leverage despite higher bad-debt reserves
Item 7.01: Regulation FD Disclosure
- Supplemental earnings information scheduled for October 29, 2026, providing investors additional operating and financial detail
- Key metrics include adjusted EPS, Adjusted EBITDA, leverage ratio, and adjusted free cash flow
Item 2.02: Results of Operations and Financial Condition
- Encompass Health reported financial results for the three and nine months ended September 30, 2026
- Press release containing detailed results attached as Exhibit 99.1
Item 8.01: Other Events
- $100 million 5.875% senior notes issued, due 2034, expanding total notes under the indenture to $600 million
- 98.75% issue price, approximately $96.9 million net proceeds after discounts and expenses
AI summaries of EHC 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for EHC
Don't miss the next EHC filing
- Alerts as it files. A push when EHC files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut EHC, by share count.
- Ask anything. An AI agent that reads every EHC filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Christie Edward M III | A | Oct 19, 2026 | 221 | $126.63 |
| Reidy Christopher R | A | Oct 19, 2026 | 284 | $126.89 |
| SCHLICHTING NANCY M | A | Oct 15, 2026 | 38 | - |
| Williams Terrance | A | Oct 15, 2026 | 28 | - |
| Christie Edward M III | A | Oct 15, 2026 | 11 | - |
| O'Connor Kevin J. | A | Oct 15, 2026 | 18 | - |
| Reidy Christopher R | A | Oct 15, 2026 | 20 | - |
| Hayes Cain A | A | Oct 15, 2026 | 4 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $4.8B | $5.4B | $5.9B | |
| Net Income | $352.0M | $455.7M | $566.2M | |
| Net Margin | 7.3% | 8.5% | 9.5% | |
| Balance Sheet | ||||
| Total Assets | $6.1B | $6.5B | $7.1B | |
| Equity | $1.6B | $2.1B | $2.4B | |
| ROE | 21.4% | 22.0% | 23.2% | |
| Per Share | ||||
| EPS | $3.47 | $4.46 | $5.54 | |
| Cash Flow | ||||
| Operating CF | $850.8M | $1.0B | $1.2B | |
Source: XBRL data in Encompass Health Corp (EHC)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate EHC share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 40 | $5.71B |
| Q2 2026 | 39 | $4.81B |
| Q1 2026 | 39 | $4.62B |
| Q4 2025 | 36 | $4.97B |
| Q3 2025 | 37 | $6.18B |
| Q2 2025 | 37 | $5.55B |
| Q1 2025 | 36 | $3.54B |
| Q4 2024 | 29 | $2.76B |
- Millennium Management+781.5K (+97%)
- T. Rowe Price Group+443.0K (+9%)
- Raymond James Financial+281.3K (+26%)
- Prudential Financial+193.9K (+261%)
- Dimensional Fund Advisors+179.3K (+10%)
- Two Sigma Investments−686.0K (-30%)
- Ameriprise Financial−294.1K (-46%)
- AQR Capital Management−273.3K (-49%)
- Goldman Sachs Group−264.8K (-17%)
- Morgan Stanley−230.2K (-20%)
- D.E. Shaw & Co−384.6K
- FMR LLC (Fidelity)−152.8K
- Mangrove Partners−5.5K
Source: 13F-HR filings on SEC EDGAR (aggregated from 293 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
EHC filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Nov 6, 2026 | - | Analysis | - |
| 10-Q | Nov 3, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Oct 28, 2026 | - | Analysis | - |
| 4 | Oct 19, 2026 | - | - | - |
| 4 | Oct 19, 2026 | - | - | - |
| 4 | Oct 19, 2026 | - | - | - |
| 4 | Oct 19, 2026 | - | - | - |
| 4 | Oct 19, 2026 | - | - | - |
| 4 | Oct 19, 2026 | - | - | - |
| 4 | Oct 19, 2026 | - | - | - |
| 4 | Oct 19, 2026 | - | - | - |
| 4 | Oct 19, 2026 | - | - | - |
| 4 | Sep 1, 2026 | - | - | - |
| 4 | Sep 1, 2026 | - | - | - |
| 8-K | Aug 13, 2026 | - | Analysis | - |
| 4 | Aug 11, 2026 | - | - | - |
| 4 | Aug 11, 2026 | - | - | - |
| 4 | Aug 11, 2026 | - | - | - |
| 10-Q | Aug 7, 2026 | Jun 30, 2026 | - | |
| 8-K | Aug 5, 2026 | - | Analysis | - |
| 4 | Jul 16, 2026 | - | - | - |
| 4 | Jul 16, 2026 | - | - | - |
| 4 | Jul 16, 2026 | - | - | - |
| 4 | Jul 16, 2026 | - | - | - |
| 4 | Jul 16, 2026 | - | - | - |
Related Health Care companies
- MD · Pediatrix Medical Group, Inc.Services-Hospitals
- SEM · SELECT MEDICAL HOLDINGS CORPServices-Hospitals
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
- ABEO · ABEONA THERAPEUTICS INC.Pharmaceutical Preparations
EHC SEC filings: frequently asked questions
Are EHC insiders buying or selling?
In the last 90 days, Encompass Health Corp (EHC) officers, directors and 10% owners reported no open-market purchases and 2 open-market sales worth $1.2 million by 2 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold EHC stock?
As of September 30, 2026, the largest Encompass Health Corp (EHC) holders among the 13F filers tracked by SignalX were BlackRock ($1.3 billion), T. Rowe Price Group ($668.0 million), Vanguard Portfolio Management LLC ($595.0 million), Vanguard Capital Management LLC ($536.8 million), State Street Corp ($387.7 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was EHC's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Encompass Health Corp (EHC) reported revenue of $5.9 billion (up 10.5% from FY2024) and net income of $566.2 million. Diluted EPS was $5.54. The figures come from the XBRL data in the 10-K.
What did EHC report in its latest 8-K?
Encompass Health Corp (EHC) filed an 8-K on November 6, 2026 reporting Item 7.01 (Regulation FD Disclosure). Sea Pines, a 90-bed joint-venture hospital, closed indefinitely after flooding caused substantial damage.
What are the latest EHC SEC filings?
Encompass Health Corp (EHC) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 3, 2026, an 8-K current report on November 6, 2026 and a Form 4 insider filing on October 19, 2026.
What is EHC's SEC CIK number?
Encompass Health Corp (EHC)'s SEC Central Index Key (CIK) is 785161. EDGAR lists every EHC filing under that number.
Ask anything about EHC
The research agent reads EHC's filings, financials, insider trades and 13F holders, then answers with sources.